⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LYEL News
Lyell Immunopharma, Inc. Common Stock
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
globenewswire.com
LYEL
Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
globenewswire.com
LYEL